RecruitingNCT04493385

The Hepatitis C Transplant Collaborative

Nationwide Hepatitis C NAT+ Cardiac Transplant Experience

Sponsor

Baylor Research Institute

Enrollment

500 participants

Start Date

Sep 16, 2019

Study Type

OBSERVATIONAL

Conditions

Transplant; Failure, Heart Hepatitis C

Summary

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This collaborative study collects data and outcomes from patients who received a heart transplant from a donor who had Hepatitis C (HCV). With new highly effective treatments for Hepatitis C, these hearts can now be transplanted safely — and this registry tracks how well patients do after receiving them. **You may be eligible if...** - You received a heart transplant from a donor who tested positive for Hepatitis C (HCV NAT+) - You are a re-transplant recipient **You may NOT be eligible if...** - You received multiple organs in the same transplant procedure (multi-organ transplantation) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.